Changes in muscle strength in individuals with statin-induced myopathy: A summary of 3 investigations

Journal of Clinical Lipidology

Volumn 9, Issue 3, 2015, Pages 351-356

  Panza, Gregory A ^a   Taylor, Beth A ^a,b   Dada, Marcin R ^a   Thompson, Paul D ^a  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF HARTFORD   (United States)

Author keywords

Isokinetic dynamometer; Muscle strength; Myopathy; Statins; Strength testing

Indexed keywords

ATORVASTATIN; EZETIMIBE; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYNAMOMETER; FEMALE; GRIP STRENGTH; HUMAN; ISOKINETIC EXERCISE; ISOMETRIC EXERCISE; LEG MUSCLE; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCULOSKELETAL SYSTEM PARAMETERS; MYALGIA; MYOPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY EXCHANGE RATIO; AGED; CHEMICALLY INDUCED; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE;

ADULT; AGED; ATORVASTATIN CALCIUM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYALGIA;

EID: 84931570407     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.01.004     Document Type: Article

References (21)

1. P.S. Phillips, R.H. Haas, and S. Bannykh Statin-associated myopathy with normal creatine kinase levels Ann Intern Med 137 2002 581 585
2. D. Scott, L. Blizzard, J. Fell, and G. Jones Statin therapy, muscle function and falls risk in community-dwelling older adults QJM 102 2009 625 633
3. G.F. Hamilton, C. McDonald, and T.C. Chenier Measurement of grip strength: validity and reliability of the sphygmomanometer and jamar grip dynamometer J Orthop Sports Phys Ther 16 5 1992 215 219
4. A. Katsiaras, A.B. Newman, and A. Kriska Skeletal muscle fatigue, strength, and quality in the elderly: the Health ABC Study J Appl Physiol (1985) 99 2005 210 216
5. D.M. Pincivero, R.M. Campy, and A.J. Coelho Knee flexor torque and perceived exertion: a gender and reliability analysis Med Sci Sports Exerc 35 10 2003 1720 1726
6. J.M. Drouin, T.C. Valovich-mcLeod, S.J. Shultz, B.M. Gansdeder, and D.H. Perrin Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements Eur J Appl Physiol 91 2004 22 29
7. G.M. Krishnan, and P.D. Thompson The effects of statins on skeletal muscle strength and exercise performance Curr Opin Lipidol 21 4 2010 324 328
8. B.A. Parker, J.A. Capizzi, and A.S. Grimaldi The effect of statins on skeletal muscle function Circulation 127 2012 96 103
9. P.D. Thompson, B.A. Parker, and P.M. Clarkson A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design Prev Cardiol 13 2010 104 111
10. G.A. Panza, B.A. Taylor, W. Roman, and P.D. Thompson Changes in muscle strength in patients with statin myalgia Am J Cardiol 114 8 2014 1215 1216
11. N.M. Fisher, K. Meksawan, and A. Limprasertkul Statin therapy depresses total body fat oxidation in the absence of genetic limitations to fat oxidation J Inherit Metab Dis 30 3 2007 388 399
12. A. Head, P.M. Jakeman, and M.J. Kendall The impact of a short course of three lipid lowering drugs on fat oxidation during exercise in healthy volunteers Postgrad Med J 69 809 1993 197 203
13. G. Paolisso, M. Barbagallo, and G. Petrella Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients Atherosclerosis 150 2000 121 127
14. B.H. Dobkin Underappreciated statin-induced myopathic weakness causes disability Neurorehabil Neural Repair 19 2005 259 263
15. J.V. Agostini, M.E. Tinetti, L. Han, G. McAvay, J.M. Foody, and J. Concato Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults J Am Geriatr Soc 55 2007 420 425
16. T.A. Ashfield, H.E. Syddall, H.J. Martin, E.M. Dennison, C. Cooper, and S.A. Aihie Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study Age Ageing 39 2010 185 191
17. T. Traustadottir, A.A. Stock, and S.M. Harman High-dose statin use does not impair aerobic capacity or skeletal muscle function in older adults Age (Dordr) 30 2008 283 291
18. T. Nishimoto, R. Tozawa, Y. Amano, T. Wada, Y. Imura, and Y. Sugiyama Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes Biochem Pharmacol 66 11 2003 2133 2139
19. K. Sakamoto, and J. Kimura Mechanism of statin-induced rhabdomyolysis J Pharmacol Sci 123 2013 289 294
20. L. Markoff, and P.D. Thompson The role of coenzyme Q10 in statin-associated myopathy: a systematic review J Am Coll Cardiol 49 23 2007 2231 2237
21. M.L. Urso, P.M. Clarkson, D. Hittel, E.P. Hoffman, and P.D. Thompson Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins Arterioscler Thromb Vasc Biol 25 12 2005 2560 2566